Presenting Companies

Enpath Medical is one of a very few companies in the world that develops and manufactures implantable stimulation leads, lead delivery systems, and lead accessories for cardiac rhythm management (CRM), neuromodulation, and hearing restoration applications. Enpath manufactures its own proprietary implantable leads, as well as serving as a contract product development and manufacturing company for OEM suppliers. Enpath Medical has been supplying implantable pacemaker leads and adapters to the CRM market since 1989 and holds a number of patents in the myocardial pacing lead segment. The firm has been successfully partnering in the development and manufacture of implantable stimulation leads for OEM suppliers in the fields of neuromodulation and hearing restoration since the mid-1990s.



Advanced Brain Monitoring, Inc. is a privately owned corporation that was founded in January 1997 with a vision of creating low cost, easy-to-use, portable systems to monitor and interpret physiological signals. Since its inception, Advanced Brain Monitoring has developed patented data acquisition technology with automated analysis software to measure the brain's electrical activity (EEG), oxygen levels in the blood, and cardiac activity. Advanced Brain Monitoring's technologies will facilitate the development of a family of reasonably priced products and services to diagnose disease, detect drowsiness, assess neurocognitive function, and evaluate pharmaceuticals. The company's software will provide real-time or off-line identification of alertness/drowsiness and transmission of reports over the Internet. Advanced Brain Monitoring has been awarded over $7 million from the National Institute of Health's Small Business Innovative Research Program to complete the development of its technologies. The company's products are still under development and not available for marketing and distribution within the United States for applications requiring FDA clearance. Advanced Brain Monitoring is preparing submissions for review by the FDA.



Cyberkinetics, Inc. is a leader in the rapidly emerging field of brain computer interfaces. Cyberkinetics’ technology allows for the creation of direct, reliable, and bi-directional interfaces between the brain and nervous system and a computer. This technology platform may allow breakthrough applications such as the translation of thought into direct computer control. Additional applications include the monitoring and treatment of psychiatric diseases including epilepsy or depression. Cyberkinetics’ lead product development effort is the Braingate™ Neural Interface Device. Based on years of pre-clinical development at Brown University, the Braingate™ is intended to provide severely disabled patients with a permanent, direct, and reliable interface to a personal computer. In late 2002, Cyberkinetics merged with a leading manufacturer of neural recording, stimulation, and signal processing equipment for neuroscience research. Through the merger, Cyberkinetics gained a world-class engineering team, manufacturing facilities and key intellectual property. The company continues to provide the BIONIC® line of neural recording arrays and data acquisition systems to preclinical researchers. The company's intellectual property estate features key exclusive licenses from Brown, the Massachusetts Institute of Technology, Emory University and University of Utah.


Texcel Medical Systems, LLC is a privately held medical device company founded in 1987 with a vision of supporting the commercialization of implantable medical devices; including pulse generators (IPGs) for neuromodulation and cardiac rhythm management, hearing restoration devices, and cardiac assist pumps. In its earliest incarnation, Texcel assisted companies like Medtronic, CPI (Guidant), and Pacesetter (St. Jude Medical) in developing and manufacturing their implantable pulse generator assembly equipment. In later years, Texcel began to manufacture pulse generators and other implantable devices for its medical device industry customers. Now, more than 15 implantable device companies rely on Texcel for services ranging from early stage product development to the manufacture of sterile labeled implantable devices. Texcel's customers include many of the rising stars in the neuromodulation field and the company is well positioned to grow with the industry. Texcel operates an FDA registered and ISO certified development and manufacturing facility in western Massachusetts.